急诊与重症研究替代知情同意模式的观点:快速系统综述
该快速系统综述检索至2024年7月31日,纳入26国145项定量与定性研究,评估急诊与重症研究中替代知情同意模式的多元观点。结果显示替代同意模式总体可接受,强调尽可能让患者和家属参与决策。疫情期间对替代同意需求增加,弱势群体观点未达共识。
要点
- 替代同意模式(延迟同意、家属/代理人同意、医生同意)总体可接受。
- 应尽可能让患者和家属参与知情同意决策过程。
- 疫情期间对替代同意方法需求增加,需加强伦理委员会参与。
核心结论
- 急诊、重症及疫情研究中使用的替代同意模式包括延迟同意、亲属/代理人同意和医生同意,总体可接受。
研究设计与样本
- 快速系统综述,检索MEDLINE、EMBASE、PsycINFO、Web of Science和CENTRAL至2024年7月31日。
- 从9974条引文中筛选289篇全文,最终纳入来自26个国家的145项合格研究,采用叙述性综合总结。
主要发现
- 替代同意模式的接受度受既往研究参与经历、重症或急诊疾病经历、感知参与风险和干预侵入性影响。
- 研究工作人员指出部分替代同意模式的潜在局限,如家属不可获得。
- 疫情研究显示替代同意方法需求增加,需更大准备度和伦理委员会参与以促进实施。
- 评估弱势群体观点的亚分析未显示共识, accommodations largely not reported。
临床怎么用
- 在急诊与重症研究中,可考虑使用替代同意模式,但应尽可能让患者和家属参与决策。
- 实施替代同意时需考虑家属可获得性等实际限制,并与伦理委员会充分沟通。
局限性
- 评估弱势群体观点的亚分析未显示共识,且 accommodations largely not reported。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Obtaining informed consent can be challenging in emergency and critical care research due to the acute and severe nature of the patient's condition. However, such research is urgently needed to inform practice and optimise patient outcomes. While alternative consent approaches have been commonly used, opinions may vary, particularly among diverse and underserved patient groups and in the context of the recent COVID-19 pandemic. The objective of this review was to assess views of alternative consent methods in emergency and critical care research. METHODS: We conducted a rapid systematic review to understand diverse opinions of alternative consent models used in emergency and critical care research with searches of MEDLINE, EMBASE, PsycINFO, Web of Science and CENTRAL carried out to July 31, 2024. We included quantitative and qualitative studies and summarised findings using narrative synthesis. We specifically investigated underserved groups and consent in the pandemic setting. RESULTS: From 9974 citations, we screened 289 full-text articles, and included 145 eligible studies from 26 countries. Consent methods included prospective informed consent, deferred consent, surrogate decision maker consent, healthcare professional consent and waived consent. Groups represented included previous trial participants, relatives of trial participants, patients, members of the general public, healthcare providers, researchers, site staff, and research ethics committees. It was recognised that prospective informed consent from the patient is not possible in all scenarios. In general, alternative consent models were acceptable, with emphasis on the inclusion of the patient and relatives in the decision-making process whenever possible. Acceptability of alternative consent models was influenced by previous research participation, experience of critical or emergency illness, perceived risk of participation, and invasiveness of the intervention. Study staff highlighted potential limitations of some alternative consent models, such as unavailability of relatives. Pandemic studies showed an increased need for alternative consent methods, and greater preparedness and engagement with ethics committees to facilitate implementation. Sub-analysis evaluating the views of underserved groups did not show consensus, and accommodations were largely not reported. CONCLUSION: Alternative consent models used for emergency, critical care and pandemic research including deferred consent, relative/surrogate decision maker consent, and physician consent were generally acceptable. TRIAL REGISTRATION: PROSPERO CRD42023408305 (April 19, 2023).
引用
- Mahon N, Hays LMC, Coy E, et al. Views on consent approaches used in emergency and critical care research: a rapid, systematic review. Trials. 2026. PMID: 41808188. doi:10.1186/s13063-026-09592-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。